These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Author: Ruiz de Souza V, Kaveri SV, Kazatchkine MD.
    Journal: Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005.
    Abstract:
    The beneficial effect of intravenous immunoglobulin (IVIg) in certain autoimmune disorders has led to the development of clinical trials in a large number of autoimmune and systemic inflammatory diseases. Experimental studies are being carried out to understand better the mechanisms of action of IVIg. In this review, we discuss the clinical use of IVIg in autoimmune disorders and outline the possible mechanisms by which IVIg may be exerting an immunoregulatory effect in various autoimmune and systemic inflammatory diseases. A clear understanding of the mechanisms of action of IVIg in autoimmune diseases will facilitate the optimization of their use as a therapeutic alternative to conventional immunosuppression.
    [Abstract] [Full Text] [Related] [New Search]